key: cord-0854036-yy9sfd3p
authors: Giannos, Panagiotis; Prokopidis, Konstantinos
title: Gut dysbiosis and long COVID‐19: Feeling gutted
date: 2022-03-07
journal: J Med Virol
DOI: 10.1002/jmv.27684
sha: 8f4d8138e5e1e5785907e9578c46d540c2741c4b
doc_id: 854036
cord_uid: yy9sfd3p

COVID-19 is primarily a respiratory illness, however there is compelling evidence proposing a lung-gut axis involved in the disease. We explored emerging evidence suggesting a possible link between dysbiosis of the gut microbiota and long-term complications from COVID-19. This article is protected by copyright. All rights reserved.

To the Editor, COVID-19 is primarily a respiratory illness, however, there is compelling evidence proposing a lung-gut axis involved in the disease. We explored emerging evidence suggesting a possible link between dysbiosis of the gut microbiota and long-term complications from COVID-19.

Emerging evidence has suggested that the pathology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may in part be explained by microbial species, 1 contributing to the inflammatory phenotype commonly seen in patients with coronavirus disease (COVID-19). 2,3 Indeed, dysbiosis of the gut microbiota has been as- Contemporary research has revealed a disruption of the gut microbiota in stool samples of SARS-CoV-2 patients that may explain the well-described cytokine storm-induced ramifications post-infection. 6 Interestingly, fecal transplantation may regenerate gut microbiota diversity, bolstering the respiratory system of patients suffering from COVID-19. 7 Considering that long-term complications following recovery from SARS-CoV-2 persistently exhibit a damaged microbial microenvironment compared to uninfected controls, 8 during a 6-month follow-up, as opposed to the aseptic group. 10 Particularly, following acute (30 days) and prolonged (3 months) 

Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults

Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host

SARS-CoV-2 infection reduces human nasopharyngeal commensal microbiome with inclusion of pathobionts

Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization

Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients

Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19

Rapid resolution of COVID-19 after faecal microbiota transplantation

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

Acetate downregulates the activation of NLRP3 inflammasomes and attenuates lung injury in neonatal mice with bronchopulmonary dysplasia

Six-month follow-up of gut microbiota richness in patients with COVID-19

Gut microbiota may not be fully restored in recovered COVID-19 patients after 3-month recovery